Cronos Group
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 7 in the most recent period (2026/Q3).
- Total institutional ownership rose 1.6 percentage points.
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 58.26% +1.62pp
- Institutions
- 224 +7
- As of
- 2026/Q3 vs. prior period
Holder types
Top holders as of 2026-03-31
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 35 buys · 15 sells
| Name | Role | Stake |
|---|---|---|
| Altria Group, Inc. | -- | 42.72% |
| Michael Gorenstein | Chairperson & CEO | 3.61% |
| Jason Adler | Independent Director | 2.70% |
| Jeffrey Jacobson | Chief Growth Officer | 0.13% |
| Anna Shlimak | Chief Financial Officer | 0.10% |
| Arye Weigensberg | Senior VP and Head of Research & Development | 0.06% |
| James Holm | Former Chief Financial Officer | 0.06% |
| Shannon Buggy | Senior VP & Global Head of People | 0.05% |
| Adam Wagner | General Manager of Cronos Israel | 0.03% |
| Terry Doucet | General Counsel | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-06 | Adam Wagner | General Manager of Cronos Israel | Derivative Exercise and Retained | +20,242 | -- |
| 2026-10-15 | Christopher Martens | General Manager | Other Derivative Acquisition | +46,875 | -- |
| 2026-08-05 | James Rudyk | Lead Independent Director | Other Derivative Acquisition | +48,859 | -- |
| 2026-08-05 | Murray Garnick | Independent Director | Other Derivative Acquisition | +48,859 | -- |
| 2026-08-05 | Jason Adler | Independent Director | Other Derivative Acquisition | +48,859 | -- |
| 2026-05-11 | Shannon Buggy | Senior VP & Global Head of People | Derivative Exercise and Sale | -9,179 | $2.75 |
| 2026-05-11 | Shannon Buggy | Senior VP & Global Head of People | Derivative Exercise and Retained | +11,443 | -- |
| 2026-05-11 | Jared Kenost | VP, Principal Accounting Officer & Controller | Derivative Exercise and Sale | -3,701 | $2.75 |
| 2026-05-11 | Jared Kenost | VP, Principal Accounting Officer & Controller | Other Derivative Acquisition | +30,000 | -- |
| 2026-05-11 | Jared Kenost | VP, Principal Accounting Officer & Controller | Derivative Exercise and Retained | +5,711 | -- |
| 2026-05-11 | Terry Doucet | General Counsel | Derivative Exercise and Sale | -5,199 | $2.73 |
| 2026-05-11 | Terry Doucet | General Counsel | Derivative Exercise and Retained | +5,398 | -- |
| 2026-05-11 | Adam Wagner | General Manager of Cronos Israel | Derivative Exercise and Retained | +10,367 | -- |
| 2026-05-09 | Jared Kenost | VP, Principal Accounting Officer & Controller | Derivative Exercise and Sale | -4,774 | $2.54 |
| 2026-05-09 | Jared Kenost | VP, Principal Accounting Officer & Controller | Derivative Exercise and Retained | +7,875 | -- |
| 2026-05-09 | Arye Weigensberg | Senior VP and Head of Research & Development | Derivative Exercise and Retained | +3,118 | -- |
| 2026-05-09 | Adam Wagner | General Manager of Cronos Israel | Derivative Exercise and Retained | +20,470 | -- |
| 2026-03-18 | Anna Shlimak | Chief Financial Officer | Derivative Exercise and Sale | -9,767 | $2.54 |
| 2026-03-18 | Anna Shlimak | Chief Financial Officer | Derivative Exercise and Retained | +18,662 | -- |
| 2026-03-15 | Arye Weigensberg | Senior VP and Head of Research & Development | Other Derivative Acquisition | +12,245 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:02:36 · For reference only, not investment advice and not tailored to your situation.
Cronos Group discussion 0 comments